RDPAC药品推广行为准则 - IFPMA

研
制
开
发
制
药
企
业
协
会
16
RDPAC药品推广行为准则
(2012年修订版)
1.1 范围
第一条 范围与定义
RDPAC准则的规范对象是会
员公司与医疗卫生专业人士及医疗
机构之间的互动交流活动,以及药
品的推广活动。
注释1-6
1.2 定义
在RDPAC准则中:
• “药品”指根据《中华人
民共和国药品管理法》第
102条的规定用于预防、
治疗、诊断人的疾病,有
目的地调节人的生理机能
并规定有适应症或者功能
主治、用法和用量的物
质,包括中药材、中药饮
片、中成药、化学原料药
及其制剂、抗生素、生化
药品、放射性药品、血
清、疫苗、血液制品和诊
RDPAC Code of Practice
2012
Article 1 Scope and Definitions
1.1 Scope
The RDPAC Code covers interac-
tions with healthcare professionals,
medical institutions, and the promotion
of pharmaceutical products.
ANNOTATION 1-6
1.2 Definitions
For the purposes of the RDPAC Code:
• “pharmaceutical product” means,
as set forth in Article 102 of the
Drug Administration Law, any articles
intended for use in the prevention,
treatment or diagnosis of
human diseases, or intended to
effect the purposive regulation of
human physiological functions,
for which indications or major
functions, usage and dosage
are prescribed. They include raw
traditional Chinese medicinal materials,
traditional medicines prepared
in ready-to-use forms, and
other prepared Chinese medicines,
medicinal chemicals and
their preparations, antibiotics,
biochemical medicines, radioactive
drugs, serums, vaccines,